AGLE MENU

About AGLE

Aeglea BioTherapeutics, Inc. (AGLE) is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AGLE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
IBB iShares Nasdaq Biotechnology Index Fund 7.6 B 7.57157E+09 215 215 0.03% 0.0003 2.3 M 2324550
ITOT iShares Core S&P Total U.S. Stock Market ETF 24.8 B 2.47988E+10 3,547 3547 0.0% 0 57 K 57346
IWC iShares Microcap ETF 860.9 M 8.60942E+08 1,382 1382 0.06% 0.0006 506 K 506248
IWM iShares Russell 2000 ETF 47.7 B 4.77409E+10 1,979 1979 0.01% 0.0001 4.7 M 4677030
IWN iShares Russell 2000 Value ETF 9.8 B 9.78864E+09 1,379 1379 0.02% 0.0002 1.7 M 1671430
IWO iShares Russell 2000 Growth ETF 9.7 B 9.65541E+09 1,153 1153 0.0% 0 258 K 257982
IWV iShares Russell 3000 ETF 10.0 B 1.00185E+10 2,882 2882 0.0% 0 65 K 65143
VTWG Vanguard Russell 2000 Growth ETF 302.7 M 3.027E+08 1,177 1177 0.0% 2.71431E-05 8 K 8396
BIB ProShares Ultra Nasdaq Biotechnology 197.0 M 1.96992E+08 226 226 0.01% 0.00010474 46 K 46242
UBIO Proshares UltraPro Nasdaq Biotechnology 27.7 M 2.77497E+07 221 221 0.01% 5.82137E-05 5 K 5444
URTY ProShares UltraPro Russell2000 106.6 M 1.06613E+08 1,991 1991 0.0% 2.56321E-05 9 K 8719
UWM ProShares Ultra Russell2000 206.3 M 2.06278E+08 1,990 1990 0.0% 3.66562E-05 17 K 16641